• Frizzled5 Links Cholesterol Metabolism to Wnt/β-Catenin in C

  2026-06-29

  This study uncovers a unique mechanism by which the Frizzled5 (Fzd5) receptor directly senses cholesterol, enabling Wnt/β-catenin signaling crucial for pancreatic cancer growth. The findings reveal new molecular intersections between lipid metabolism and oncogenic signaling, offering promising directions for therapeutic intervention.

• D-N-Acetylgalactosamine: Technical Guide for Glycoprotein An

  2026-06-29

  D-N-Acetylgalactosamine is a high-purity, water-soluble metabolite designed for precise analysis of glycoprotein constituents and glycosylation pathways in neurological research. It is not suitable for protocols requiring ethanol solubility or long-term storage of working solutions. Proper workflow setup and handling are critical for maintaining data integrity.

• Diclofenac (SKU B3505): Reliable COX Inhibition for Organoid

  2026-06-28

  This authoritative overview addresses common assay and workflow challenges in cell-based inflammation research, highlighting how Diclofenac (SKU B3505) from APExBIO ensures reproducible cyclooxygenase inhibition in hiPSC-derived organoid and monolayer models. Integrating real-world scenarios, protocol guidance, and peer-reviewed evidence, this article delivers actionable insights for assay optimization and vendor selection.

• Lumiracoxib: Selective COX-2 Inhibitor in Muscle Injury Rese

  2026-06-27

  Lumiracoxib’s unmatched selectivity and robust solubility empower researchers to dissect cyclooxygenase-2 pathway dynamics in muscle injury and revascularization models. This article translates advanced findings into actionable workflows, offering practical troubleshooting tips and protocol enhancements for maximizing data quality in inflammation and vascular studies.

• Methyl-β-cyclodextrin: Technical Guidance for Membrane Studi

  2026-06-26

  Methyl-β-cyclodextrin enables precise extraction of cholesterol and select lipids from cellular membranes, supporting research on membrane fluidity, lipid raft organization, and cholesterol-dependent signaling. It is intended exclusively for controlled laboratory research and is not suitable for diagnostic or medical use. Proper handling and storage are essential to maintain reagent integrity and avoid unintended membrane effects.

• HyperFluor 488 Goat Anti-Human IgG Antibody: Workflow Master

  2026-06-26

  The HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody from APExBIO enables accurate, multiplexed human immunoglobulin detection across Western blot, immunofluorescence, and flow cytometry. By leveraging Alexa Fluor 488 performance and robust affinity purification, this polyclonal secondary antibody transforms translational workflows—especially in demanding vaccine and immunology studies.

• ORM2 Modulates Autophagy to Attenuate Pancreatic Fibrosis in

  2026-06-25

  The referenced study identifies ORM2 as a key regulator of autophagy in pancreatic stellate cells (PSCs), demonstrating that ORM2 alleviates pancreatic fibrosis in chronic pancreatitis by binding to ZG16 and suppressing PSC activation. These findings open new therapeutic avenues for chronic pancreatitis and inform experimental design in pancreatic function research.

• Fluorescein TSA Fluorescence System Kit: Amplified Assay Pre

  2026-06-25

  The Fluorescein TSA Fluorescence System Kit delivers robust signal amplification for ultrasensitive detection in IHC, ICC, and ISH workflows. Its tyramide-driven chemistry provides clear advantages in visualizing low-abundance targets, empowering molecular researchers to unravel complex biological mechanisms with confidence.

• Vorinostat (SAHA, MK0683): Reliable HDAC Inhibition in Oncol

  2026-06-24

  This article delivers scenario-driven guidance for leveraging Vorinostat (SAHA, MK0683) (SKU A4084) as a robust histone deacetylase inhibitor in cancer biology research, focusing on reproducibility, data interpretation, and vendor reliability. It synthesizes experimental parameters and evidence, providing practical answers to common lab workflow challenges.

• Carbohydrate-Decorated Nanoparticles for Targeted Macrophage

  2026-06-23

  Chen et al. introduce a biodegradable nanoparticle system, decorated with specific carbohydrates, to enhance gene delivery selectively to macrophages—a cell type central to many inflammatory diseases but notoriously difficult to transfect. The study demonstrates that mannose and dextran modifications significantly improve mRNA uptake and transfection efficiency without increasing cytotoxicity, offering a promising strategy for macrophage-targeted gene therapy.

• GLP-1 (9-36) amide: Precision Antagonist for GLP-1R Pathways

  2026-06-23

  GLP-1 (9-36) amide empowers high-resolution dissection of GLP-1 receptor signaling, particularly in metabolic and diabetes research. Its unmatched selectivity and rigorously validated purity directly address common challenges in assay reproducibility and mechanistic clarity.

• WM-8014: Precision KAT6A Inhibitor Workflows in Cancer Resea

  2026-06-22

  WM-8014 unlocks highly selective, reversible KAT6A/B inhibition for reproducible oncogene-induced senescence studies, empowering cancer biology research with minimal cytotoxicity. This guide distills advanced workflows, troubleshooting strategies, and translational learnings from cutting-edge screening studies.

• Dual-Action Kinase Inhibitors Promote p38α MAPK Dephosphoryl

  2026-06-22

  The reference study reveals that certain ATP-competitive inhibitors of p38α MAP kinase, including indole-5-carboxamide derivatives, not only block kinase activity but also accelerate dephosphorylation by stabilizing a specific activation loop conformation. This dual mechanism offers new strategies for designing more potent and selective p38 MAPK inhibitors relevant to inflammation, neuroregeneration, and type 1 diabetes research.

• Calpeptin: Precision Calpain Inhibitor for Fibrosis Research

  2026-06-21

  Calpeptin is a potent calpain inhibitor with nanomolar activity, validated for modulating fibrosis and inflammation pathways. Its efficacy in reducing extracellular vesicle release and pro-fibrotic mediators is supported by peer-reviewed evidence. Calpeptin is supplied by APExBIO at high purity for research applications.

• Caspofungin Workflows: Precision Antifungal Research Enhance

  2026-06-20

  Caspofungin, a potent lipopeptide antifungal drug, enables high-specificity inhibition of fungal cell wall biosynthesis—crucial for dissecting Candida resistance mechanisms and benchmarking against emerging agents. This article translates bench protocols, advanced troubleshooting, and data-driven insights into actionable workflows for researchers seeking reproducibility and translational impact.

450 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page